Navigation Links
Novus Scientific Announces the World's 1st Long-Term Absorbable Mesh as an Alternative to Non-Absorbable Synthetic Mesh
Date:9/26/2011

SINGAPORE, Sept. 26, 2011 /PRNewswire/ -- Novus Scientific today announced TIGR® Matrix Surgical Mesh, the world's first and only long-term resorbable mesh, as an alternative to permanent synthetic mesh. First introduced in the US in 2010, TIGR® Matrix Surgical Mesh is currently being used in many surgical applications as an alternative to permanent synthetic mesh and expensive biologic devices.

Characteristics of TIGR® Matrix Surgical Mesh
TIGR® Matrix Surgical Mesh is knitted from two different synthetic absorbable fibers, possessing different degradation characteristics. The first fiber, making up approximately 40% of the matrix by weight, is a copolymer of glycolide, lactide, and trimethylene carbonate. The second fiber, making up approximately 60% of the matrix by weight, is a copolymer of lactide, and trimethylene carbonate. Both fibers degrade by bulk hydrolysis once implanted.

Based on the product's absorption characteristics, in vitro testing showed that the first fiber retains its functional capabilities for 1-2 weeks and in vivo studies in the abdominal wall of sheep showed that the first fiber was fully absorbed after 4 months. The same in vitro testing showed that the second fiber retains its functional capabilities for 6 months and in vivo studies in the abdominal wall of sheep indicated that the second fiber is completely absorbed after approximately 36 months.

"We at Novus Scientific have long prided ourselves on identifying clinical need and developing innovative products to address that need. We are pleased to highlight the fact that TIGR® Matrix Surgical Mesh is a viable alternative to permanent synthetic mesh on both a physiological treatment level and a budgetary level when used by physicians performing surgeries that reinforce soft tissue where weakness exists," said Thomas Engstrom, Founder and CEO of Novus Scientific.

"Surgeons want to provide the best treatment for their patients. Now, TIGR® Matrix Surgical Mesh offers surgeons an alternative to non-absorbable synthetic mesh," commented James Archetto, President of Novus Scientific, Inc.

Mark Swierzewski, MD, a urological surgeon from Tampa, FL stated, "TIGR® Matrix has been a part of my practice since 2010. It provides me and my patients with a viable alternative to non-absorbable synthetic mesh."

About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of absorbable synthetic medical devices. Visit our PRESSROOM: http://www.mynewsdesk.com/pressroom/novus-scientific

TIGR® is a trademark of Novus Scientific Pte. Ltd

CONTACT:
jim.archetto@novusscientific.com
781-577-2599


'/>"/>
SOURCE Novus Scientific
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
2. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
3. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
6. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
7. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
8. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
9. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
10. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
11. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... 23, 2016  Guerbet announced today that it has ... Horizon Award . One of 12 suppliers ... for its support of Premier members through exceptional local ... and commitment to lower costs. ... of our outstanding customer service from Premier," says ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
Breaking Medicine News(10 mins):